Triple-negative breast cancer--current status and future directions.

By O. Gluz, C. Liedtke, N. Gottschalk, L. Pusztai, U. Nitz, N. Harbeck. 2009

648 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Yun Bai
2. Tianwei Yu
3. Zhaohui S. Qin
4. Pankaj Kumar
5. Rupali Aggarwal
6. Rendong Yang
7. Matthew Stephens
8. Sharon R. Browning

Citations in the corpus

• EgoNet: identification of human disease ego-network modules (2014, background): “Mc Ilroy M, Fleming FJ, Buggy Y, Hill AD, Young LS: Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.”
• An overview of triple-negative breast cancer (2016, background): “It remains unknown whether EGFR TKIs add any value to the therapy for TNBC [156].”